Author name: kylie

The rare kidney disorders market is projected to grow at a

Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases   London Roots Analysis has announced the addition of the “Rare Kidney Disorders Market, 2022–2035” report to […]

The rare kidney disorders market is projected to grow at a Read More »

Patient Recruitment and Retention Service Providers

Clinical trials form an essential part of the overall drug development process, evaluating the safety and efficacy of a drug candidate. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials.   However, the conduct of such trials is often fraught with challenges,

Patient Recruitment and Retention Service Providers Read More »

The mini bioreactors and microbioreactors market is anticipated to grow

Given the need for accelerated bioprocessing operations, low-volume bioreactors have emerged as a relatively economic solution for parallelized cell cultivations and applications ranging from media development to process optimization   Roots Analysis has announced the addition of “Mini Bioreactors Market, 2022-2035” report to its list of offerings.   Mini bioreactors and microbioreactors enable faster experimental

The mini bioreactors and microbioreactors market is anticipated to grow Read More »

The cell and gene therapy CROs market is anticipated to grow

Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years.   Roots Analysis has announced the addition of Cell and Gene Therapy CRO Market , 2022-2035” report to its

The cell and gene therapy CROs market is anticipated to grow Read More »

The DNA data storage market is anticipated to grow

Exponential increase in amount of digital data being generated, coupled to the limitations of conventional storage mediums, has created a need for sustainable storage options and DNA data storage has garnered significant interest as an alternative     London   Roots Analysis has announced the addition of DNA Data Storage Market, 2021-2035” report to its list

The DNA data storage market is anticipated to grow Read More »

Sustainable, biodegradable and Eco- Friendly Packaging

Sustainable packaging is defined as packaging that is safe for individuals, as well as the environment, while meeting all requirements for performance, cost and ease of fabrication. Further, the product should be specially designed in order to minimize usage of raw material and optimize energy use.   The term sustainability is derived from the Latin word sustinere, which means to

Sustainable, biodegradable and Eco- Friendly Packaging Read More »

The patient recruitment and retention services market is projected to grow at a steady pace, till 2035, claims Roots Analysis

  Clinical trials are a fundamental requirement for evaluating the safety and efficacy of novel therapeutics; patient recruitment and retention are two major bottlenecks during the conduct of clinical studies and contribute to inconclusive results, additional costs and trial delays. Roots Analysis has announced the addition of “Patient Recruitment and Retention Services Market (3rd Edition),

The patient recruitment and retention services market is projected to grow at a steady pace, till 2035, claims Roots Analysis Read More »

MORE THAN 70 COMPANIES CURRENTLY CLAIM TO MANUFACTURE PEPTIDE-BASED THERAPEUTICS

The in-house development of peptide API requires necessary expertise and capabilities, including design, construction and maintenance of a facility which demands significant capital investments. Therefore, several small drug developers and, at times, certain pharma giants as well, have started outsourcing their manufacturing operations to contract service providers. Over the years, the popularity of biologics has

MORE THAN 70 COMPANIES CURRENTLY CLAIM TO MANUFACTURE PEPTIDE-BASED THERAPEUTICS Read More »